Search results
Mankind Pharma competes with EQT-ADIA combo for Rs 14,000 cr buyout of BSV Group from Advent
The Economic Times· 4 hours agoThe buyout of BSV Group (formerly Bharat Serum & Vaccines Ltd) has now boiled down to a fight between Mankind Pharma and Europe's largest buyout group EQT ...
Mankind Pharma inks pact with Takeda to commercialise acidity drug in India
Business Standard India· 1 day agoThe agreement allows Mankind Pharma to launch the novel drug for treating Gastroesophageal Reflux...
Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India - ET HealthWorld | Pharma
The Economic Times· 1 day agoThe pharma company has signed a Non-Exclusive Patent License Agreement with Takeda Pharmaceuticals...
Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in India
Financial Express· 1 day agoVonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related...
Ipca, Glenmark, Sun, Zydus, Mankind, Ajanta, power Pharma market growth in June, that softened over...
Livemint· 2 days agoStock Market Today: Indian Pharma market growth at 6.7% yoy in June softened over April and May....
Pharma sector likely to report 8-10% revenue growth led by domestic business - CNBC TV18
CNBC TV18· 23 hours agoPharmaceutical companies are expected to kick off FY25 with around 8-10% growth in revenue led by...
Block deals: Canada Pension Plan sells 0.5% in Nykaa for Rs 256 cr; Hema CIPEF offloads 0.46% in ...
The Economic Times· 7 days agoThrough the stake sale, Canada Pension Plan took home about Rs 256 crore. At the end of March...
₹771 Crore Block Deal Shakes Up Mankind Pharma Stock | India Infoline
India Infoline· 7 days agoOn July 10, about 37 lakh shares, or 0.9% of Mankind Pharma’s equity, were sold in block agreements for a total of ₹771 core. The participants to the sale ...
Pharma and healthcare sector seals $4.1 bn deals in Q2 2024: Report
Business Standard India· 24 hours agoHealthcare funding India Q2: The average deal size also saw a jump, rising from $9.7 million in Q1...
Stock market update: Nifty Pharma index advances 0.09% in an upbeat market
The Economic Times· 1 day agoThe Nifty Pharma index was trading 0.09 per cent up at 20862.7.